Immune Checkpoint Inhibitor Toxicity in Head and Neck Cancer: From Identification to Management

Immune Checkpoint Inhibitor Toxicity in Head and Neck Cancer: From Identification to Management

Benefiting from the continuously clarifying underlying biology of immune checkpoints and ligand–receptor interactions, the emergence of new anticancer treatment strategy, immunotherapy has shown substantial benefits on several liquid and solid tumors. Immune checkpoint inhibitors (ICIs) can block th...

Full description

Bibliographic Details
Main Authors: Haiyang Wang, Abdulkadir Mustafa, Shixi Liu, Jun Liu, Dan Lv, Hui Yang, Jian Zou
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Pharmacology
Subjects:
head and neck cancer
immunotherapy
immune checkpoint inhibitors
immune-related adverse events
programmed cell death 1
programmed death-ligand 1
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.01254/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.01254/full

Similar Items